Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center.
Wiesweg M, Ting S, Reis H, Worm K, Kasper S, Tewes M, Welt A, Richly H, Meiler J, Bauer S, Hense J, Gauler TC, Köhler J, Eberhardt WE, Darwiche K, Freitag L, Stamatis G, Breitenbücher F, Wohlschlaeger J, Theegarten D, Derks C, Cortes-Incio D, Linden G, Skottky S, Lütkes P, Dechêne A, Paul A, Markus P, Schmid KW, Schuler M. Wiesweg M, et al. Among authors: linden g. Eur J Cancer. 2013 Oct;49(15):3076-82. doi: 10.1016/j.ejca.2013.06.014. Epub 2013 Jul 19. Eur J Cancer. 2013. PMID: 23876834
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.
Kasper S, Meiler J, Knipp H, Höhler T, Reimer P, Steinmetz T, Berger W, Linden G, Reis H, Markus P, Paul A, Dechêne A, Schumacher B, Kostbade K, Virchow I, Ting S, Worm K, Schmid KW, Herold T, Wiesweg M, Schuler M, Trarbach T. Kasper S, et al. Among authors: linden g. Clin Colorectal Cancer. 2020 Dec;19(4):236-247.e6. doi: 10.1016/j.clcc.2020.03.003. Epub 2020 Mar 19. Clin Colorectal Cancer. 2020. PMID: 32737003 Clinical Trial.
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).
Virchow I, Treckmann JW, Prasnikar N, Linden G, Markus P, Schumacher B, Albers D, Herold T, Ting S, Schmidt H, Radunz S, Wiesweg M, Siveke J, Schuler M, Kasper S. Virchow I, et al. Among authors: linden g. Oncol Res Treat. 2023;46(3):89-99. doi: 10.1159/000529012. Epub 2023 Jan 9. Oncol Res Treat. 2023. PMID: 36623497 Clinical Trial.
Analysis of 5,070 consecutive pedicle screws placed utilizing robotically assisted surgical navigation in 334 patients by experienced pediatric spine deformity surgeons: surgical safety and early perioperative complications in pediatric posterior spinal fusion.
Widmann RF, Wisch JL, Tracey OC, Zucker CP, Feddema T, Miller F, Linden GS, Erickson M, Heyer JH. Widmann RF, et al. Among authors: linden gs. Spine Deform. 2024 Mar 31. doi: 10.1007/s43390-024-00854-7. Online ahead of print. Spine Deform. 2024. PMID: 38556583
Proton therapy induces a local microglial neuroimmune response.
Voshart DC, Klaver M, Jiang Y, van Weering HRJ, van Buuren-Broek F, van der Linden GP, Cinat D, Kiewiet HH, Malimban J, Vazquez-Matias DA, Reali Nazario L, Scholma AC, Sewdihal J, van Goethem MJ, van Luijk P, Coppes RP, Barazzuol L. Voshart DC, et al. Among authors: van der linden gp. Radiother Oncol. 2024 Apr;193:110117. doi: 10.1016/j.radonc.2024.110117. Epub 2024 Mar 6. Radiother Oncol. 2024. PMID: 38453539 Free article.
Radiotherapy induces persistent innate immune reprogramming of microglia into a primed state.
Voshart DC, Oshima T, Jiang Y, van der Linden GP, Ainslie AP, Reali Nazario L, van Buuren-Broek F, Scholma AC, van Weering HRJ, Brouwer N, Sewdihal J, Brouwer U, Coppes RP, Holtman IR, Eggen BJL, Kooistra SM, Barazzuol L. Voshart DC, et al. Among authors: van der linden gp. Cell Rep. 2024 Feb 27;43(2):113764. doi: 10.1016/j.celrep.2024.113764. Epub 2024 Feb 14. Cell Rep. 2024. PMID: 38358885 Free article.
313 results